Samrat Pharmachem [SAMRATPH] vs Styrenix Performance [STYRENIX] Detailed Stock Comparison

Samrat Pharmachem

BSE
Loading...

Styrenix Performance

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Samrat Pharmachem wins in 7 metrics, Styrenix Performance wins in 12 metrics, with 0 ties. Styrenix Performance appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricSamrat PharmachemStyrenix PerformanceBetter
P/E Ratio (TTM)20.0019.23Styrenix Performance
Price-to-Book Ratio1.343.72Samrat Pharmachem
Debt-to-Equity Ratio13.8134.02Samrat Pharmachem
PEG Ratio-0.18-1.27Styrenix Performance
EV/EBITDA13.6113.91Samrat Pharmachem
Profit Margin (TTM)1.72%7.00%Styrenix Performance
Operating Margin (TTM)-0.06%7.61%Styrenix Performance
EBITDA Margin (TTM)N/A7.61%N/A
Return on Equity9.91%20.14%Styrenix Performance
Return on Assets (TTM)5.85%10.26%Styrenix Performance
Free Cash Flow (TTM)$-105.99M$-3.82BSamrat Pharmachem
Dividend Yield0.29%2.34%Styrenix Performance
1-Year Return-44.72%-2.95%Styrenix Performance
Price-to-Sales Ratio (TTM)0.341.35Samrat Pharmachem
Enterprise Value$1.06B$46.24BStyrenix Performance
EV/Revenue Ratio0.381.43Samrat Pharmachem
Gross Profit Margin (TTM)2.99%27.12%Styrenix Performance
Revenue per Share (TTM)$908$1,860Styrenix Performance
Earnings per Share (Diluted)$15.59$128.45Styrenix Performance
Beta (Stock Volatility)-0.400.66Samrat Pharmachem
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Samrat Pharmachem vs Styrenix Performance Stock Performance Analysis

Loading Price Chart...

Samrat Pharmachem
Styrenix Performance
Samrat Pharmachem Stock Overview | Styrenix Performance Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Samrat Pharmachem-1.52%3.37%-4.23%-18.68%-2.82%-21.57%
Styrenix Performance0.21%4.74%-4.72%-22.58%-5.02%-18.96%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Samrat Pharmachem-44.72%-69.64%176.70%598.52%1,337.94%1,818.75%
Styrenix Performance-2.95%190.19%384.27%203.33%555.22%2,066.16%

News Based Sentiment: Samrat Pharmachem vs Styrenix Performance

Samrat Pharmachem

News based Sentiment: MIXED

October was a month of contrasting fortunes for Samrat Pharmachem, with a significant initial stock surge quickly followed by a decline to a 52-week low. This volatility, combined with mixed financial results, creates a complex investment picture that requires careful consideration.

View Samrat Pharmachem News Sentiment Analysis

Styrenix Performance

News based Sentiment: MIXED

Styrenix reported a mixed bag of results in Q1 FY26, with strong revenue growth offset by declining profitability. The upcoming board meeting and market sentiment analysis add complexity, making this a significant but not entirely positive month for investors.

View Styrenix Performance News Sentiment Analysis

Performance & Financial Health Analysis: Samrat Pharmachem vs Styrenix Performance

MetricSAMRATPHSTYRENIX
Market Information
Market Cap i₹1.03B₹43.54B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,85037,062
90 Day Avg. Volume i1,30629,629
Last Close₹307.00₹2,470.50
52 Week Range₹289.00 - ₹425.00₹2,220.50 - ₹3,498.00
% from 52W High-27.76%-29.37%
All-Time High₹1,250.00 (Sep 19, 2022)₹3,498.00 (Jun 09, 2025)
% from All-Time High-75.44%-29.37%
Growth Metrics
Quarterly Revenue Growth-0.06%0.35%
Quarterly Earnings Growth-0.06%-0.15%
Financial Health
Profit Margin (TTM) i0.02%0.07%
Operating Margin (TTM) i0.00%0.08%
Return on Equity (TTM) i0.10%0.20%
Debt to Equity (MRQ) i13.8134.02
Cash & Liquidity
Book Value per Share (MRQ)₹232.02₹663.93
Cash per Share (MRQ)₹1.70₹61.62
Operating Cash Flow (TTM) i₹1.26M₹-3,519,400,000
Levered Free Cash Flow (TTM) i₹71.12M₹2.35B
Dividends
Last 12-Month Dividend Yield i0.29%2.34%
Last 12-Month Dividend i₹1.00₹62.00

Valuation & Enterprise Metrics Analysis: Samrat Pharmachem vs Styrenix Performance

MetricSAMRATPHSTYRENIX
Price Ratios
P/E Ratio (TTM) i20.0019.23
Forward P/E iN/AN/A
PEG Ratio i-0.18-1.27
Price to Sales (TTM) i0.341.35
Price to Book (MRQ) i1.343.72
Market Capitalization
Market Capitalization i₹1.03B₹43.54B
Enterprise Value i₹1.06B₹46.24B
Enterprise Value Metrics
Enterprise to Revenue i0.381.43
Enterprise to EBITDA i13.6113.91
Risk & Other Metrics
Beta i-0.400.66
Book Value per Share (MRQ) i₹232.02₹663.93

Financial Statements Comparison: Samrat Pharmachem vs Styrenix Performance

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)SAMRATPHSTYRENIX
Revenue/Sales i₹756.52M₹9.44B
Cost of Goods Sold i₹733.90M₹6.88B
Gross Profit i₹22.62M₹2.56B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-456,000₹717.50M
EBITDA i₹8.16M₹998.40M
Pre-Tax Income i₹2.08M₹705.40M
Income Tax i₹4.37M₹186.20M
Net Income (Profit) i₹-2.29M₹519.20M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)SAMRATPHSTYRENIX
Cash & Equivalents i₹483,000₹976.50M
Total Current Assets i₹1.03B₹13.61B
Total Current Liabilities i₹495.83M₹6.61B
Long-Term Debt i₹0₹3.77B
Total Shareholders Equity i₹718.00M₹11.68B
Retained Earnings i₹687.11M₹7.40B
Property, Plant & Equipment i₹0₹8.53B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)SAMRATPHSTYRENIX
Operating Cash Flow iN/A₹251.00M
Capital Expenditures iN/A₹-380.00M
Free Cash Flow iN/A₹870.00M
Debt Repayment iN/A₹-1.15B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricSAMRATPHSTYRENIX
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i1,85037,062
Average Daily Volume (90 Day) i1,30629,629
Shares Outstanding i3.09M17.59M
Float Shares i1.26M8.96M
% Held by Insiders i0.59%0.49%
% Held by Institutions i0.00%0.12%

Dividend Analysis & Yield Comparison: Samrat Pharmachem vs Styrenix Performance

MetricSAMRATPHSTYRENIX
Last 12-Month Dividend i₹1.00₹62.00
Last 12-Month Dividend Yield i0.29%2.34%
3-Year Avg Annual Dividend i₹1.67₹88.00
3-Year Avg Dividend Yield i0.17%3.06%
3-Year Total Dividends i₹5.00₹264.00
Ex-Dividend DateSep 19, 2024Aug 21, 2025